Ahmedabad, India

Sameer Agarwal

USPTO Granted Patents = 3 


Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Ahmedabad, IN (2022)
  • Gujarat, IN (2024)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Sameer Agarwal

Introduction

Sameer Agarwal, an accomplished inventor based in Ahmedabad, India, has made significant contributions to the field of pharmaceuticals. With a robust portfolio consisting of three patents, Agarwal has focused his research on developing novel compounds aimed at modulating NOD-like receptor family proteins, particularly NLRP3, which are implicated in various diseases.

Latest Patents

Agarwal's latest inventions include:

1. **Substituted Sulfoximine Derivatives**: This innovation pertains to novel heterocyclic compounds characterized by a general formula (I) along with their tautomers, stereoisomers, enantiomers, and pharmaceutically acceptable salts. The invention emphasizes these compounds as NLRP3 modulators and their potential applications in treating diseases or conditions involving interleukin 1β activity and interleukin-18 (IL-18).

2. **Substituted Sulfonylurea Derivatives**: This patent involves another set of novel heterocyclic compounds represented by a general formula (I), inclusive of their pharmaceutically acceptable salts, solvates, enantiomers, diastereomers, and polymorphs. The findings indicate a strong relevance of these compounds in developing treatments for conditions linked to interleukin 1β activity, while also contributing to the understanding of NLRP3 modulation.

Career Highlights

Throughout his career, Sameer Agarwal has worked with prominent organizations such as Zydus Lifesciences Limited and Cadila Healthcare Limited. His experience at these companies has contributed significantly to his expertise in pharmaceutical innovations and patent development.

Collaborations

During his tenure in the industry, Agarwal has collaborated with esteemed colleagues, including Rajiv Sharma and Pravin Iyer. These professional relationships have fostered a shared commitment to advancing innovative pharmaceutical solutions.

Conclusion

Sameer Agarwal's dedication to pharmaceutical research and innovation exemplifies the impact of inventors in the healthcare industry. With his continued work on NLRP3 modulators and numerous patents, he is likely to play a pivotal role in the development of vital treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…